H.R.5651 - Prescription Drug User Fee Amendments of 2012
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (11)
All Bill Titles
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Reform Act of 2012 as passed house.
- Official: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Reform Act of 2012 as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| All Actions | |
|---|---|
| May 9th | Referred to the House Committee on Energy and Commerce. |
| May 9th | Introduced in House |
| May 11th | Referred to the Subcommittee on Health. |
| May 25th | Reported by the Committee on Energy and Commerce. H. Rept. 112-495. |
| May 25th | Placed on the Union Calendar, Calendar No. 348. |
| May 30th | DEBATE - The House proceeded with forty minutes of debate on H.R. 5651. |
| May 30th | Considered under suspension of the rules. |
| May 30th | Mr. Upton moved to suspend the rules and pass the bill, as amended. |
| May 30th | At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. |
| May 30th | Considered as unfinished business. |

U.S. Congress - H.R.5651 Prescription Drug User Fee Amendments of 2012



